RxDoctor Payments Data

Daniel Rhoads

Clinical Pathology · Cleveland, OHNPI 1386033561

Payments from drug & device makers

$983,233in general payments, 2019–2025

Across 142 payments — averaging $6924.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BD$435K
  • Biomerieux Inc$153K
  • Roche Molecular Systems, Inc.$137K
  • Qiagen, LLC$99K
  • Genmark Diagnostics, Inc.$65K
  • Abbott$45K
  • plus $50K from 8 others

What the payments were for

  • Consulting fees$4,80053%
  • Speaking & faculty fees$2,72030%
  • Travel & lodging$1,29414%
  • Food & beverage$2713%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
BD10$434,710
Biomerieux Inc97$153,343
Roche Molecular Systems, Inc.7$136,504
Qiagen, LLC4$98,881
Genmark Diagnostics, Inc.4$64,915
Abbott3$44,819
Accelerate Diagnostics Inc.1$36,628
Cepheid4$5,773
Luminex Corporation6$4,800
Roche Diagnostics Corporation1$1,520
Life Technologies Corporation1$1,200
Merck1$79
Melinta Therapeutics, LLC2$46
Viiv Healthcare Company1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical pathology providers in Ohioto place this figure against a meaningful peer group, so we don't.

Other clinical pathology in Cleveland

Where these figures come from

Is this you, or does something look wrong? →